Jonathan Kolatch’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.8M Hold
84,800
3.54% 9
2026
Q1
$24.8M Hold
84,800
3.68% 8
2025
Q4
$29.7M Buy
84,800
+32,300
+62% +$10.9M 3.18% 6
2025
Q3
$17M Buy
+52,500
New +$16.3M 1.64% 7
2015
Q3
Sell
-75,000
Closed -$12.3M 45
2015
Q2
$12.3M Sell
75,000
-25,000
-25% -$3.99M 1.47% 23
2015
Q1
$15.4M Sell
100,000
-250,000
-71% -$35.6M 1.78% 21
2014
Q4
$44M Sell
350,000
-50,000
-13% -$6.18M 4.62% 7
2014
Q3
$47.8M Hold
400,000
5.1% 4
2014
Q2
$43M Hold
400,000
4.53% 7
2014
Q1
$39.8M Hold
400,000
4.54% 7
2013
Q4
$37M Hold
400,000
4.33% 9
2013
Q3
$33.4M Hold
400,000
4.39% 9
2013
Q2
$32.7M Buy
+400,000
New +$29.9M 4.39% 7

Other funds holding ELV

Jonathan Kolatch's ELV Position: Q2 2026 in Review

Jonathan Kolatch held its Elevance Health (ELV) position steady in Q2 2026 at 84,800 shares worth $32.8M. The position accounts for 3.54% of the portfolio, ranked #9.

Jonathan Kolatch first reported a position in ELV in Q2 2013 and has held it in 13 quarters since. The position peaked at $47.8M in Q3 2014. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Jonathan Kolatch held 84,800 shares of Elevance Health worth $32.8M as of Q2 2026.
  • Jonathan Kolatch left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 3.54% of Jonathan Kolatch's portfolio in Q2 2026, its #9 holding.
  • Jonathan Kolatch first reported a position in Elevance Health in Q2 2013 and has held it in 13 quarters since.
  • Jonathan Kolatch's Elevance Health position peaked at $47.8M in Q3 2014.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Redwood Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.